Biotalys’ products are a new generation of protein-based biocontrols designed to effectively and selectively target pests and pathogens with new modes of action.
Based on its unique groundbreaking technology platform, Biotalys is building a versatile product pipeline against key pests and diseases, with EVOCA™, our first biofungicide approved by the EPA in the US, and pending approval in the EU.
EVOCA received regulatory approval by the EPA in the U.S. in December 2025, and in Florida and California in 2026. In the EU, the Netherlands provided a positive recommendation and the review by EFSA is currently ongoing, with an expected final decision in 2027.
